<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Osmina-------------------------------------------------------->
<div class="bodyDiv" id="idOsmina">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Osmina</h2>
    </div>

<b>Product Orientation & Presentation:</b><br>
  
Parabasal cells:<br>
Parabasal cells are the smallest epithelial cells seen on a typical vaginal smear. They are round or nearly round and have a high nuclear to cytoplasmic ratio. Parabasal cells are prevalent on smears taken during diestrus and anestrus, and not uncommon during early proestrus.<br><br>

Apoptosis:<br>
Apoptosis is the process of programmed cell death. It is used during early development to eliminate unwanted cells; for example, those between the fingers of a developing hand. In adults, apoptosis is used to rid the body of cells that have been damaged beyond repair. Apoptosis also plays a role in preventing cancer.<br><br>
 
Vaginal atrophy:<br>
Vaginal atrophy (also called atrophic vaginitis) is a condition where the lining of the vagina gets drier and thinner. This results in itching, burning and pain during sex, among other symptoms. The condition also includes urinary tract problems such as urinary tract infections (UTIs) and frequent urination.<br><br>

Vaginal dryness:<br>
Vaginal dryness is a common symptom during and after menopause, but it can happen at any age and for various reasons. Vaginal dryness usually results from low estrogen levels. Estrogen is the hormone that keeps the lining of the vagina lubricated, thick, and elastic:<br>


Dysuria:<br>
painful or difficult urination.<br><br>

Dyspareunia:<br>
Painful intercourse.<br><br>
 
<img src="img/Osmina_1.jpg" alt="" class="responsive-IMG" width="375" height="300">
<br><br>
<img src="img/Osmina_2.jpg" class="responsive-IMG" width="375" height="300">
<br><br>
<img src="img/Osmina_3.jpg" class="responsive-IMG" width="375" height="300">
<br><br>
<img src="img/Osmina_4.jpg" class="responsive-IMG" width="375" height="300">
<br><br>

Short detailing:<br>
Dear Sir/Madam,<br>
Good Morning/Evening!<br>
আপনার daily practice-এ এমন অনেক patients পেয়ে থাকেন যারা vulvo-vaginal atrophy, vaginal
dryness, dyspareunia সমস্যায় ভুগে থাকে। pre-menopausal, menopausal & post-menopausal women-দের ক্ষেত্রে estrogen hormone কমে গেলে vaginal superficial cell কমে যায় ও parabasal cell বেড়ে যাওয়ায় apoptosis এর ফলে এই সমস্যাগুলো হয়। এই সকল patients দের ক্ষেত্রে conventional therapy যেমন-  HRT (Hormonal Replacement Therapy), topical estrogen এবং lubricant ব্যবহার করা হয়ে থাকে।<br>
কিন্তু স্যার/ম্যাডাম, আপনি জানেন এই গুলোর কিছু limitation আছে যেমন- Hormonal Replacement Therapy (HRT) এর কারণে breast cancer হতে পারে এবং lubricant ও topical estrogen burning, irritation & infection তৈরী করে কিন্তু none of those treatment options can cure
the root problem.<br>
এই সমস্যা সমাধানের জন্য Navana Pharma introduces 1st time in Bangladesh US FDA approved non-hormonal selective estrogen receptor modulator Osmina preparation of Ospemifene 60 mg Tablet.<br>
Osmina non-hormonal selective estrogen হওয়ায়  vaginal superficial cell, epithelial cell height vaginal weight increase করে, parabasal cell decrease করায় apoptosis prevent করে এবং vaginal pH কমিয়ে দিয়ে infection এর ঝুঁকি কমায়। Tissue selective হওয়ায় এর side effect নেই। <br>
Osmina dyspareunia symptoms 56% পর্যন্ত কমিয়ে দেয় এবং Vulvovaginal atrophy কমিয়ে দিয়ে painfree intercourse নিশ্চিত করে।
Osmina safe treatment option কারণ ৫২ সপ্তাহ পর্যন্ত সেবন করা যায়। একটি tablet দিনে মাত্র ১ বার সেবন করতে হয় যা পরবর্তী ২ সপ্তাহের মধ্যে আশানুরুপ ফল দেয়।
মূল্যঃ  ৩০ (ত্রিশ) টাকা মাত্র।<br><br>

<li>Prescribing Information</li>
<li>Composition: </li>
Osmina Tablet: Each film coated tablet contains Ospemifene INN 60 mg, <li>Pharmacology: </li>
Osmina is an estrogen receptor
agonist/antagonist with tissue selective effects. Its biological actions are mediated through binding to estrogen receptors. This binding results
In activation of estrogenic pathways in some tissues (agonism) and blockage of estrogenic pathways in others (antagonism). 
<li>Indication:</li>
Osmina is an estrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia & vaginal dryness, a symptom of
vulvar and vaginal atrophy, due to menopause. <li>Dosage & Administration: </li>
Osmina is an estrogen agonist/antagonist which has agonistic
effects on the endometrium. Use of Osmina should be for the shortest duration consistent with treatment goals and risks for the individual
women. One tablet should be taken orally once daily with food or as directed by the physician. <li>Contraindication: </li>
Ospemifene is
contraindicated in women with any of the following conditions. Undiagnosed abnormal genital bleeding. Known or suspected
estrogen-dependent neoplasia. Active deep Vein thrombosis, pulmonary embolism or a history of these conditions. Active arterial
thromboembolic disease for example, stroke and myocardial infarction (MI) or a history of these conditions. Hypersensitivity to Ospemifene
or any of its ingredients. Ospemifene is contraindicated in women who are or may become pregnant. Warnings & Precautions:
<li>Cardiovascular: </li>
Coronary heart disease, Venous thromboembolism Known, suspected or history of breast cancer and endometrial cancer
<li>Severe Hepatic Impairment. Side Effects:</li>
 The most common side effects (21%) include: hot flash, vaginal discharge, muscle spasms,
headache, excessive sweating (hyperhidrosis), heavy vaginal bleeding, night sweats. Use in <li>Pregnancy & Lactation:</li>
 Not recommended
during pregnancy. Ospemifene is likely to increase adverse outcomes during pregnancy & labor. It is not known whether Ospemifene is
excreted in human breast milk. There is no data on the effects of Ospemifene on breastfed child and milk production. Use in Children &
<li>Adolescents: </li>
Ospemifene is not indicated in children and adolescents. Drug Interactions: • Ospemifene should not be used concomitantly
with estrogen or estrogen agonist/antagonist. Do not use fluconazole and ketoconazole concomitantly with Ospemifene as they increase
serum concentrations of Ospemifene. . Do not use rifampin concomitantly with Ospemifene as It decreases serum concentration of
<li>Ospemifene. Overdosage: </li>
There is no adequate data on overdose of Ospemifene. <li>Storage: Store below 30'C. away from light and in a dry
place. Keep out of the reach of children. <li>Packing: </li>
Osmina Tablet: Each box contains 2x10 tablets in Alu-Alu blister pack and an insert.<br>
 
Product Orientation & Presentation:<br>
<table class="table1">
 <tr>
    <th>Brand Name:</th>
    <th></th>
  </tr>

  <tr>
 
    <td>Generic & Strength:</td>
	<td></td>
    
  </tr>
  
  <tr>
    <td>Dosage Form:</td>
    <td></td>
    
  </tr>
	 
  <tr>
    <td>Therapeutic Class:</td>
	<td></td>
    
    </tr>

   
  </tr>
	 
  <tr>
    <td>Sub Therapeutic class: </td>
	<td></td>
    
    </tr>
		
  
  <tr>
    <td>Commercial Pack:</td>
	<td> </td>
    
  </tr>
	 
   <tr>
    <td>Price (TP):</td>
    <td> <br>
        </td>
	
   </tr>	
	 
   <tr>
 
    <td>Flavour </td>
    <td>.</td>
	 
  </tr>
  
  <tr>
 
    <td>Indication </td>
    <td> 
	 
  </tr>
  <tr>
<td>Pregnancy: 
</td>
<td>

</td>
</tr>
<tr>
<td>Lactation: 
</td>
<td>


</td>
</tr>

  
  <tr>
 
    <td>Children: </td>
    <td>
</td>
	 
  </tr>
  
   <tr>
 
    <td>Brand Name Justification: </td>
    <td>   </td>
	 
  </tr>
  
 <tr>
<td>Dosage & Administration: 
</td>
<td>
&#x2022; 
</td>
</tr>
<tr>
<td>Key Selling Points: 
</td>
<td>
&#x2022; <br>

</td>
</tr>
<tr>
<td>Target Doctor: 
</td>
<td>
&#x2022; <br>


</td>
</tr>
<tr>
<td>Side effects: 
</td>
<td>
&#x2022; 

</td>
</tr>
<tr>
<td colspan="4">
---
</td>
</tr>
</table>


<table class="table6">
<tr>
<td>
Mechanisms of Action
</td>
</tr>
<tr>
<th> 
&#8681;
</th>
</tr>
<tr>
<td>
&#9660; 
</td>
</tr>
<tr>
<td>

</td>
</tr>
<tr>
<td>
&#9660; 
</td>
</tr>
<tr>
<td>

</td>
</tr>
<tr>
<td>
&#9660; 
</td>
</tr>
<tr>
<td>

</td>
</tr>
<tr>
<td>
&#9660; 
</td>
</tr>
<tr>
<td>

</td>
</tr>
</table>
</div>
<footer>
  <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Osmina</div></center><!--End Line---->
</body>
</html>